It has been repeatedly shown that patients affected by autoimmune RO60-dependent conditions have a higher frequency of malignancies, including melanoma, T-cell lymphoma, non-Hodgkin lymphoma, and breast carcinoma [90,93,94,95,96]. Here, RO60 is linked to melanoma.